| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2019 | 1,524.00 | 1,559.40 | 1,520.20 | 1,557.20 | 9,727,122 |
| Apr 22, 2019 | 1,526.80 | 0.00 | 0.00 | 1,524.40 | 0 |
| Apr 19, 2019 | 1,526.80 | 1,536.20 | 1,523.20 | 1,524.40 | 6,710,359 |
| Apr 18, 2019 | 1,526.80 | 1,536.20 | 1,523.20 | 1,524.40 | 6,710,359 |
| Apr 17, 2019 | 1,548.20 | 1,552.10 | 1,529.80 | 1,540.80 | 8,295,458 |
| Name | GlaxoSmithKline | Epic | GSK |
|---|---|---|---|
| ISIN | GB0009252882 | Currency | GBX |
| Type | Equity | Trading Segment | SET1 |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 1,500 | Prev Close | 1,540.40 |
| Shares in Issue (m) | 4,987.64 | Market Cap (£m) | 77,667.58 |
| PE Ratio | 21.13 | Div per Share (p) | 80.00 |
| Div Yield | 5.14 | Div Cover | 0.92 |
| EPS | 73.70 | EPS Growth (%) | 134.71 |
| PEG | 0.16 | DPS Growth (%) | 0.00 |
| ROCE | 13.49 | Net Gearing | 87.00 |
| Quick Ratio | 0.51 | Current Ratio | 0.75 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 24 Apr | Jefferies International | Buy | 1,540.40 | 1,750.00 | - | Reiterates |
| 23 Apr | Jefferies International | Buy | 1,540.40 | 1,750.00 | - | Reiterates |
| 10 Apr | Barclays Capital | Equal weight | 1,540.40 | 1,600.00 | - | Reiterates |
| 09 Apr | Shore Capital | Hold | 1,540.40 | - | - | Reiterates |
| 05 Apr | Deutsche Bank | Hold | 1,540.40 | 1,520.00 | - | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 16 Apr 2019 | Simon Dingemans | Dividend Reinvestment | 1,766 @ 1,565.60p | £27,648.50 |
| 16 Apr 2019 | Emma Walmsley | Dividend Reinvestment | 2,340 @ 1,565.60p | £36,635.04 |
| 16 Apr 2019 | Simon Dingemans | Dividend Reinvestment | 4,619 @ 1,565.60p | £72,315.06 |
| 16 Apr 2019 | Emma Walmsley | Dividend Reinvestment | 1,856 @ 1,550.09p | £28,769.67 |
| 22 Feb 2019 | Simon Dingemans | Exercise | 266 @ 1,013.00p | £2,694.58 |
